BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27615005)

  • 21. Late effects after radiotherapy for locally advanced cervical cancer: comparison of two brachytherapy schedules and effect of dose delivered weekly.
    Hellebust TP; Kristensen GB; Olsen DR
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):713-8. PubMed ID: 19427739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
    Lawton CA; Yan Y; Lee WR; Gillin M; Firat S; Baikadi M; Crook J; Kuettel M; Morton G; Sandler H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e795-801. PubMed ID: 22330999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
    Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian time-dependent tumor suppressor function of period genes.
    Yang X; Wood PA; Ansell C; Hrushesky WJ
    Integr Cancer Ther; 2009 Dec; 8(4):309-16. PubMed ID: 19926612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma.
    Harima Y; Nagata K; Harima K; Oka A; Ostapenko VV; Shikata N; Ohnishi T; Tanaka Y
    Cancer; 2000 Jan; 88(1):132-8. PubMed ID: 10618615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor.
    Granda TG; Liu XH; Smaaland R; Cermakian N; Filipski E; Sassone-Corsi P; Lévi F
    FASEB J; 2005 Feb; 19(2):304-6. PubMed ID: 15545298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries.
    Ohno T; Nakano T; Kato S; Koo CC; Chansilpa Y; Pattaranutaporn P; Calaguas MJ; de Los Reyes RH; Zhou B; Zhou J; Susworo R; Supriana N; Dung TA; Ismail F; Sato S; Suto H; Kutsutani-Nakamura Y; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1522-9. PubMed ID: 17919839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
    Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
    Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer.
    Chen SW; Liang JA; Yang SN; Hung YC; Yeh LS; Shiau AC; Lin FJ
    Gynecol Oncol; 2004 Oct; 95(1):208-14. PubMed ID: 15385134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Ki-67 and PC10 immunostaining.
    Oka K; Nakano T; Hoshi T
    Cancer; 1993 Nov; 72(9):2621-7. PubMed ID: 8402484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and Severity of Acute Toxicity of Pelvic Radiotherapy for Gynecological Cancer.
    Hafiz A; Abbasi AN; Ali N; Khan KA; Qureshi BM
    J Coll Physicians Surg Pak; 2015 Nov; 25(11):802-6. PubMed ID: 26577965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The late effects of proton irradiation on cell growth, cell cycle arrest and apoptosis in a human melanoma cell line.
    Ristic-Fira A; Nikolic D; Petrovic I; Ruzdijic S; Raffaele L; Sabini MG; Cirrone GA; Cuttone G; Farruggia G; Masotti L; Kanazir DT
    J Exp Clin Cancer Res; 2001 Mar; 20(1):135-43. PubMed ID: 11370820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.
    Tacev T; Ptácková B; Strnad V
    Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma.
    Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V
    J BUON; 2007; 12(2):221-6. PubMed ID: 17600876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.